Asuman Bunsuz joins the lab to study the molecular basis of efficacy of GPCR pharmacological ligands by combining computational and experimental approaches.
Asuman Bunsuz joins the Veprintsev lab
Updated: Nov 25, 2019
Updated: Nov 25, 2019
Asuman Bunsuz joins the lab to study the molecular basis of efficacy of GPCR pharmacological ligands by combining computational and experimental approaches.
Edward and Akhil will focus on genetic basis for GPCR-related diseases.